Delivery Order SPE2DB22D1106-SPE2DB24FFEH7

Award Date 7/29/24
Potential Completion Date 7/30/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pediarix 0.5 ML syringes. The contract, a delivery order valued at $1,797.15, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of September 5, 2024. The contract is a firm-fixed-price arrangement and does not have a set-aside designation. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Pediarix 0.5 ML syringes. The firm-fixed-price delivery order, valued at $4,975.20, has an ultimate completion date of September 16, 2024. The contract is not set aside and is funded through DLA, a defense agency. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,732.78, is for the delivery of Pediarix 0.5 mL syringes. This is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $4,925.62 and is for the delivery of Pediarix 0.5 ML Syringes. The contract is a Firm Fixed Price Delivery Order with a completion date of June 13, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a $3,269.36 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 0.5 mL Pediarix syringes. This contract has an ultimate completion date of August 2, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with DLA and other federal agencies to provide a wide range of medical commodities, including prescription drugs and vaccines, to support military...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pediarix 0.5 ML syringes. The award, with a ceiling value of $98,452.50, was made by the Defense Logistics Agency (DLA) Troop Support Medical on September 10, 2021, with a completion date of September 13, 2021. The contract is a firm fixed price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Pediarix 0.5 ML Syringe 0.5ML, a pharmaceutical product, to the U.S. government. The contract has a ceiling value of $1,228.78 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is part of the Department of Defense (DoD). Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.5 mL Pediarix syringes. The contract has a ceiling value of $9,414.79 and a completion date of September 16, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp's Corporate Office Division holds numerous Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,067.70 firm fixed-price delivery order is for the supply of the pharmaceutical product Pediarix (0.5 mL syringe) with a completion date of June 6, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,421.04 firm fixed-price delivery order is for the supply of 0.5mL Pediarix syringes, with a period of performance through December 17, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB24FFEH7
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pediarix 0.5 ML syringes. The delivery order, valued at $11,829.06, is a Firm Fixed Price contract with a completion date of July 30, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, worth up to $999,999,999 and $750,000 respectively, to provide a range of pharmaceutical and medical supplies to support military treatment programs, veterans' healthcare, and other federal beneficiaries. This specific award is not designated as a set-aside contract.

Generated 10/28/24, 9:46 AM